Why are blood spots collected from a newborn’s heel useful for metabolic disease screening?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

Collecting blood spots from a newborn’s heel—a procedure often referred to as the Guthrie test—is a vital method for the early detection of inborn errors of metabolism. These rare genetic disorders can cause severe developmental delays or permanent brain damage if left untreated, as they often involve the toxic accumulation of metabolites due to enzyme deficiencies.12

The utility of this screening process lies in several key factors:

  • Early Intervention: Many metabolic diseases, such as phenylketonuria, are treatable if identified shortly after birth. Early diagnosis allows for timely interventions, such as specialized diets, which can prevent or attenuate serious health consequences and improve long-term prognosis.234
  • Efficiency and Scope: By blotting a small droplet of blood onto an absorbent paper card, clinicians can easily collect and transport samples. Modern technologies like mass spectrometry and tandem mass-spectrometry allow laboratories to screen these dried blood spots for multiple metabolic disorders simultaneously, making it a cost-effective way to monitor large populations for dozens of conditions.123
  • Proactive Management: Because infants with these disorders may appear healthy at birth, screening provides a critical window to initiate care before symptoms manifest or irreversible damage occurs.23